GENEVA, Jan. 9, 2025
/PRNewswire/ -- LIAN Group, investor and operator, announces
the launch of Vitaura, a consolidation business in the aesthetic
medicine, surgery, and longevity sector. With a similar format as
the former Cheeze Dentistry Network, the objective is to create a
network of excellence that provides integrated support to clinics
and practitioners, ensuring high-quality standards and fostering
the optimization of resources across the various clinics.
The Italian market has benefited from significant growth in
recent years due to continuously expanding demand, ranking
9th globally in 2023 with 757,000 procedures performed
and an estimated value exceeding $300
million. In this context, the sector has seen the rise of
numerous small operators, significantly contributing to the
fragmentation of a market where aggregation models are currently
almost non-existent.
Vitaura acquires and consolidates well-established entities
across the territory, offering an integrated centralized management
model that includes administrative, financial, and strategic
marketing support. This approach allows physicians to focus
exclusively on clinical activities, patient care, and professional
development, while also leveraging synergies among the different
clinics.
Vitaura announced the first acquisition, the Medicina
Estetica Zazzaron clinic, operating in 2 locations in Veneto and ranking among the top 10 clinics
nationally. The clinic was founded and is managed by Dr. Michela
Zazzaron, who will continue to lead the clinic. Dr Andrea Grassi comes on board as COO and Head of
Business Development to support Vitaura's expansion with his vast
experience in the field.
Agreements are going to be finalized for the acquisition of 2
additional locations in Tuscany
and over the next 36 months of the investment period, 8 further
acquisitions are planned, with the aim of expanding the Vitaura
network nationwide.
"We would like to emphasize the concept of a network rather
than a group, where each acquired clinic will retain its identity
and substantial medical-operational autonomy in managing client
relationships. This is to preserve as much as possible the bond of
trust between physicians and patients built over time," stated
Matteo Cardarelli, Director and Head
of Investments in Italy at LIAN
Group. "The goal is to undertake a consolidation path that has
impacted various healthcare sectors in recent years, and which now
involves aesthetic medicine and surgery. This initiative is part of
the Healthcare Platform vertical we have been developing for some
time now, which has seen several operations finalized in recent
months."
TEAM AND INVOLVED ADVISORS
LIAN Group Team:
Fiorenzo
Manganiello (Managing Partner & Co-Founder),
Matteo Cardarelli (Director
– Head of Investments in Italy), Michele Di
Minno (Director), Jacopo
Spoto (Senior Analyst).
Legal Advisors:
Gianni & Origoni supported LIAN Group with a team led by
Donato Romano (Partner) and
Vito Quaglietta
(Associate).
Giovannelli e Associati supported Medicina Estetica
Zazzaron with a team led by Alessandro
Giovannelli (Partner), Matteo Bruni (Senior Associate).
Deal Structuring and Corporate Advisory:
Studio Legale e Tributario TaxNet supported LIAN Group with
Andrea Maria Ciotti.
M&A Advisor:
Studio Pea Commercialisti supported Medicina Estetica Zazzaron
with Dr. Fabrizio Pea.
Bank Financing:
Banca Profilo financed the acquisition with a team led by
Alessio Muretti (Deputy Head of IB) and Mattia Zacchetti (Senior Analyst).
USEFUL LINKS:
LIAN Group Website: https://liangroup.io/
LIAN Group LinkedIn:
https://www.linkedin.com/company/liangroup
Vitaura Website: https://vitaura.it/en/
Vitaura LinkedIn:
https://www.linkedin.com/company/joinvitaura
CONTACT: Matteo Cardarelli,
mc@liangroup.io
Logo -
https://mma.prnewswire.com/media/2488616/LIAN_Group_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lian-group-strengthens-its-position-in-aesthetic-medicine-with-the-launch-of-vitaura-302347095.html
SOURCE LIAN Group
